C

Caribou Biosciences
D

CRBU

2.23000
USD
-0.08
(-3.46%)
Market Closed
Volume
170,262
EPS
0
Div Yield
0
P/E
-2
Market Cap
232,232,321
OverviewSignalsIdeasNews
Related Instruments
    CL
    1.740
    (1.75%)
    100.910 USD
    COP
    -2.820
    (-2.54%)
    108.380 USD
    F
    -0.120
    (-1.11%)
    10.700 USD
    FCX
    -1.770
    (-3.90%)
    43.630 USD
    M
    MRO
    -0.642
    (-2.29%)
    27.415 USD
    P
    PXD
    0
    (0%)
    0.000000 USD
    VLO
    -5.380
    (-3.33%)
    156.370 USD
    XOM
    -1.700
    (-1.43%)
    116.890 USD
News

Title: Caribou Biosciences

Sector: Healthcare
Industry: Biotechnology
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPRplatform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipelineof allogeneic CAR-T and CAR-NK cell therapies.